Safety and Tolerability of Daptomycin Rapid Infusion: Implications for Nationwide Shortage of Intravenous Fluids

Nicholas Feola^{1

2}, Leslie Lee^{1

2}, Abhay Dhand^{2

3}

Affiliations

¹ Pharmacy, Westchester Medical Center, Valhalla, NY.
² Antimicrobial Stewardship, Westchester Medical Center, Valhalla, NY.
³ Department of Medicine and Surgery, Westchester Medical Center/New York Medical College, Valhalla, NY.

Nicholas Feola et al. Am J Ther. 2025.

. 2025 May 8;32(4):e376-e377.

doi: 10.1097/MJT.0000000000001888. eCollection 2025 Jul-Aug.

Nicholas Feola^{1

2}, Leslie Lee^{1

2}, Abhay Dhand^{2

3}

¹ Pharmacy, Westchester Medical Center, Valhalla, NY.
² Antimicrobial Stewardship, Westchester Medical Center, Valhalla, NY.
³ Department of Medicine and Surgery, Westchester Medical Center/New York Medical College, Valhalla, NY.

No abstract available

Conflict of interest statement

The authors have no conflicts of interest to declare.

1. Cubicin [package insert]. Lexington, MA: Cubist Pharmacueticals; 2013.
1. Chakraborty A, Roy S, Loeffler J, et al. Comparison of the pharmacokinetics, safety and tolerability of daptomycin in healthy adult volunteers following intravenous administration by 30 min infusion or 2 min injection. J Antimicrob Chemother. 2009;64:151–158.
1. Aoki I, Ishikawa K, Wakana A, et al. Evaluation of the safety, tolerability, and pharmacokinetics of a single bolus injection of daptomycin in healthy Japanese subjects. J Infect Chemother. 2015;21:170–175.
1. Britt NS, Potter EM, Patel N, et al. Comparative effectiveness and safety of standard-medium-and high-dose daptomycin strategies for the treatment of vancomycin-resistant enterococcal bacteremia among veterans affairs patients. Clin Infect Dis. 2017;64:605–613.
1. Dhand A, Sakoulas G. Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia. Clin Ther. 2014;36:1303–1316.